Impact of Obesity on Heart Transplantation Outcomes

Fouad Chouairi1, Aidan Milner2, Sounok Sen2

  • 1Duke University Department of Internal Medicine Durham NC.

Insights

Obesity in heart failure patients inversely impacts heart transplant likelihood and increases post-transplant death risk. However, a revised allocation system improved transplant rates for obese individuals.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Obesity Research

Background:

  • Patients with obesity and advanced heart failure face significant hurdles in heart transplantation.
  • Limited data exist on waitlist and transplantation outcomes for this specific patient group.

Purpose of the Study:

  • To assess the impact of obesity on heart transplantation outcomes.
  • To investigate the effects of the updated organ procurement and transplantation network allocation system on obese patients.

Main Methods:

  • A cohort study analyzed adult heart transplant candidates from the United Network for Organ Sharing database (January 2006 - June 2020).
  • Patients were stratified by Body Mass Index (BMI) categories.
  • Outcomes including transplantation rates, waitlist mortality, and post-transplant mortality were analyzed.

Main Results:

  • Higher BMI categories showed a decreased likelihood of receiving a heart transplant, with the highest BMI group (40-55 kg/m²) having the lowest transplant probability.
  • Patients in the two highest BMI categories faced a significantly higher risk of post-transplantation death.
  • Following the allocation system change, patients with obesity (BMI 30-55 kg/m²) demonstrated increased likelihood of undergoing transplantation.

Conclusions:

  • An inverse relationship exists between Body Mass Index and heart transplant eligibility.
  • Increased BMI is linked to a higher risk of mortality after heart transplantation.
  • The revised organ allocation system has positively impacted heart transplantation rates for patients with obesity.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
13
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
13
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
76
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
15
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
691
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
575